Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
INTS holding history
Intensity Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INTS overviewAll 13F holders of INTSFull Q2 2026 holdings
- Shares (Q2 2026)
- 20
- Value
- $82
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 20 | $82 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 20 | $118 | <0.1% | −480−96.0% | Reduced | Holders |
| Q4 2025 | 500 | $205 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 500 | $121 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 500 | $154 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 500 | $985 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 500 | $880 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 500 | $1.91K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 500 | $2.45K | <0.1% | +500 | New | Holders |